UK Medicines and Healthcare Products Regulatory Agency (MHRA) issues an Early Access to Medicines Scheme (EAMS) positive scientific opinion for Avelumab as First-Line Maintenance Treatment for patients with Locally Advanced or Metastatic Urothelial Carcinoma
Feltham (Merck) & Walton Oaks (Pfizer) – Merck and Pfizer announced today that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued...